0001708138-21-000082.txt : 20210915
0001708138-21-000082.hdr.sgml : 20210915
20210915160354
ACCESSION NUMBER: 0001708138-21-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210913
FILED AS OF DATE: 20210915
DATE AS OF CHANGE: 20210915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BROWN MICHAEL S
CENTRAL INDEX KEY: 0001174475
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211255454
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-09-13
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001174475
BROWN MICHAEL S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2021-09-13
4
M
0
2479
380.95
A
3370
D
Common Stock
2021-09-13
4
M
0
3613
413.33
A
6983
D
Common Stock
2021-09-13
4
M
0
3612
413.33
A
10595
D
Common Stock
2021-09-13
4
S
0
100
636.74
D
10495
D
Common Stock
2021-09-13
4
S
0
200
637.29
D
10295
D
Common Stock
2021-09-13
4
S
0
676
638.64
D
9619
D
Common Stock
2021-09-13
4
S
0
203
639.2
D
9416
D
Common Stock
2021-09-13
4
S
0
100
640.77
D
9316
D
Common Stock
2021-09-13
4
S
0
100
641.12
D
9216
D
Common Stock
2021-09-13
4
S
0
400
642.62
D
8816
D
Common Stock
2021-09-13
4
S
0
100
643.49
D
8716
D
Common Stock
2021-09-13
4
S
0
100
644.89
D
8616
D
Common Stock
2021-09-13
4
S
0
100
645.66
D
8516
D
Common Stock
2021-09-13
4
S
0
100
646.28
D
8416
D
Common Stock
2021-09-13
4
S
0
151
647.58
D
8265
D
Common Stock
2021-09-13
4
S
0
962
648.48
D
7303
D
Common Stock
2021-09-13
4
S
0
838
649.46
D
6465
D
Common Stock
2021-09-13
4
S
0
1800
650.4
D
4665
D
Common Stock
2021-09-13
4
S
0
3712
651.1
D
953
D
Common Stock
2021-09-13
4
S
0
62
652.26
D
891
D
Common Stock
5000
I
by SLAT
Common Stock
7662
I
by Trust
Non-Qualified Stock Option (right to buy)
380.95
2021-09-13
4
M
0
2479
0.0
D
2028-01-02
Common Stock
2479
0
D
Non-Qualified Stock Option (right to buy)
413.33
2021-09-13
4
M
0
3613
0.0
D
2025-01-02
Common Stock
3613
3612
D
Non-Qualified Stock Option (right to buy)
413.33
2021-09-13
4
M
0
3612
0.0
D
2025-01-02
Common Stock
3612
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Michael S. Brown
2021-09-15